Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us


Glaucoma Therapeutics Market- Robust Pipeline to Pave Grounds for Growth

Press release Description

Albany, New York, July 23, 2018: Manufacturers operating in healthcare globally are making significant and notable attempts to come up with efficient products for eye care. Key manufacturers are making deliberate efforts to avail effective services in a bid to enhance the vision of patients. Those efforts have, in turn, created new avenues for growth of glaucoma therapeutics market. These insights are derived from a new report, titled “Glaucoma Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2024,” recently added to the all-inclusive repository of Market Research Reports Search Engine (MRRSE).

Key manufacturers in the global market are sparing no efforts in intensifying the drug pipeline of combination drugs, which is further speculated to elevate growth facets of the glaucoma therapeutics market. Moreover, surging expenses by patients and availability of a progressive healthcare infrastructure are foretold to bode well for growth of the market down the lane.

Glaucoma Therapeutics Market- Amelioration of Socio-economic Living Conditions to Provide Impetus

The growing need to offer improved eye care and preserve the vision of the patients among healthcare providers has resulted in the development of enhanced therapeutic options for the treatment of glaucoma. Although eye drop has been accepted as a widely-used conventional treatment option, the market has also been observing an evident shift towards combination drugs lately. A robust pipeline of combination drugs, therefore, ensures steady growth curve for the market. Some of the great instances of this development are Aerie Pharmaceuticals’ pipeline of combination drugs including norepinephrine transport inhibitor (NETi) and Rho Kinase Inhibitor (ROCKi).

Additionally, an upliftment in socio-economic quotient of people in emerging countries has proliferated the expenses. This surge in expenses has not only led to an increase in healthcare expenditure but has also paved ways for rising awareness adjunct to a healthy lifestyle. This, in turn, is driving early detection of glaucoma and fostering the demand for glaucoma therapeutics. On the contrary, the possible adverse effects of glaucoma drugs and considerable demand for generic drugs are likely to be the key roadblocks in the coming years.

Glaucoma Therapeutics Market- North America to Showcase Exponential Growth

North America is poised to exhibit strong growth in the coming years in the light of rising geriatric population and quick access to several treatment options. Furthermore, increasing awareness regarding among patients regarding glaucoma and development of supportive reimbursement policies and few other factors are anticipated to fuel growth of the North America glaucoma therapeutics market.

Moreover, Europe is forecasted to manifest remarkable growth during the forecast timeline. The growth can be attributed to the ever-growing demand for topical eye drops and expected introduction of combined medication products. With medical tourism picking up the steam, Asia Pacific is forecasted to embark on a journey of phenomenal growth. On the other hand, the Middle East and Africa and Latin America are projected to witness sluggish growth over the time.

Some of the prominent players listed in the competitive landscape of the report include Allergan Inc., Aristo Pharmaceuticals, Merck & Co., Fera Pharmaceuticals, Teva Pharmaceuticals, Pfizer Inc., Santen Pharmaceuticals, Valeant Pharmaceuticals, Aerie Pharmaceuticals, and Novartis AG.

Browse Full Global Glaucoma Therapeutics Market Report with TOC :

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.


State Tower
90, State Street
Suite 700
Albany, NY – 12207
United States

Telephone: +1-518-730-0559